We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERV
1201
DELISTED
Verve Therapeutics
VERV
$3K ﹤0.01%
141
IMGN
1202
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
693
KDNY
1203
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3K ﹤0.01%
153
ABSI icon
1204
Absci
ABSI
$1.17B
$2K ﹤0.01%
270
ACET icon
1205
Adicet Bio
ACET
$77.6M
$2K ﹤0.01%
7
+3
+75% +$690
AFMD
1206
DELISTED
Affimed
AFMD
$2K ﹤0.01%
41
AKRO
1207
DELISTED
Akero Therapeutics
AKRO
$2K ﹤0.01%
119
ALXO icon
1208
ALX Oncology
ALXO
$262M
$2K ﹤0.01%
138
ATAI icon
1209
AtaiBeckley Inc
ATAI
$2.66B
$2K ﹤0.01%
468
AVIR icon
1210
Atea Pharmaceuticals
AVIR
$370M
$2K ﹤0.01%
242
BAND
1211
CALL
Bandwidth Inc
BAND
$1.18B
$2K ﹤0.01%
+50
New +$2.4K
BVS icon
1212
Bioventus
BVS
$889M
$2K ﹤0.01%
173
COLL icon
1213
Collegium Pharmaceutical
COLL
$1.18B
$2K ﹤0.01%
76
CRBU icon
1214
Caribou Biosciences
CRBU
$146M
$2K ﹤0.01%
176
DAWN
1215
DELISTED
Day One Biopharmaceuticals
DAWN
$2K ﹤0.01%
181
EOLS icon
1216
Evolus
EOLS
$397M
$2K ﹤0.01%
162
LKFT
1217
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$2K ﹤0.01%
32
GLUE icon
1218
Monte Rosa Therapeutics
GLUE
$1.82B
$2K ﹤0.01%
136
GOSS icon
1219
Gossamer Bio
GOSS
$101M
$2K ﹤0.01%
260
HUMA icon
1220
Humacyte
HUMA
$168M
$2K ﹤0.01%
301
IGMS
1221
DELISTED
IGM Biosciences
IGMS
$2K ﹤0.01%
88
NBP
1222
NovaBridge Biosciences American Depositary Shares
NBP
$186M
$2K ﹤0.01%
144
IMVT icon
1223
Immunovant
IMVT
$7.93B
$2K ﹤0.01%
394
IPSC icon
1224
Century Therapeutics
IPSC
$364M
$2K ﹤0.01%
159
JANX icon
1225
Janux Therapeutics
JANX
$912M
$2K ﹤0.01%
121

Similar funds

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.